Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04415281 · ClinicalTrials.gov registry record · NA
Photobiomodulation for the Management of Temporomandibular Disorder Pain
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04415281 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 14 participants.
The verdict
NCT04415281, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Photobiomodulation (PBM), is FDA-approved for temporary relief of muscle and joint pain, but there is no indication for TMD. Our goal in this study is to conduct a clinical trial of multimodal PBM for TMD pain. Also, we propose to determine if PBM-induced changes in inflammation contribute to PBM's analgesic effects. This study will be a double-blind, sham-controlled, randomized trial testing the efficacy of PBM for pain related to TMD.
Interventions
- DEVICE THOR® laser system
- DEVICE sham THOR® laser system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-04-28 |
| Est. Completion | 2022-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04415281
The ClinicalTrials.gov registry entry for NCT04415281 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which THOR® laser system is the first listed.
NCT04415281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04415281 about?
NCT04415281 is a clinical study titled "Photobiomodulation for the Management of Temporomandibular Disorder Pain". Photobiomodulation (PBM), is FDA-approved for temporary relief of muscle and joint pain, but there is no indication for TMD. Our goal in this study is to conduct a clinical trial of multimodal PBM for TMD pain. Also, we propose to determine if PBM-induced changes in inflammation contribute to PBM's ...
What is the current status of trial NCT04415281?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2021-04-28. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT04415281?
The interventions under investigation include: THOR® laser system (DEVICE), sham THOR® laser system (DEVICE).
Who is sponsoring clinical trial NCT04415281?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.